JB Pharma Advocates Renewable Energy for Growth

25 Oct 2024 CW Team

JB Pharma has underscored the critical importance of adopting renewable energy sources to meet its future energy needs and support sustainability initiatives. The pharmaceutical company recognizes that transitioning to clean energy is not just a responsibility but a strategic move to enhance its operational efficiency and reduce its environmental impact.

As JB Pharma seeks to align its manufacturing processes with sustainable practices, the company is actively exploring various renewable energy solutions. This transition is expected to significantly decrease its carbon footprint, contributing to global efforts against climate change while also fostering a more resilient supply chain.

The management emphasizes that investing in renewable energy sources will lead to cost efficiency in the long run. By leveraging solar, wind, and other renewable options, JB Pharma aims to secure energy for its operations while adhering to stringent environmental standards. This commitment reflects a broader industry trend toward energy transition, where companies recognize the necessity of integrating eco-friendly practices into their business models.

JB Pharma's proactive approach highlights the growing recognition among pharmaceutical firms of the need for energy security and regulatory compliance. The company is keen on collaborating with stakeholders and industry partners to promote innovation in energy solutions and drive the adoption of green initiatives across the sector.

By committing to renewable energy, JB Pharma not only supports its growth ambitions but also demonstrates its dedication to corporate responsibility and sustainable development. This strategy positions the company as a leader in the industry, prepared to navigate the challenges and opportunities of a rapidly changing energy landscape while ensuring a positive impact on the environment.

Infrastructure Urban

10 Mar 2026

ABB to Invest Rs 6.25 Billion to Expand India Manufacturing

ABB recently announced plans to invest approximately Rs 6.25 billion ($75 million) in India during 2026 to expand its manufacturing footprint and research and development capabilities. The investment follows more than $35 million spent in 2025 and reflects the company’s continued focus on strengthening its ‘local-for-local’ strategy in the country.The investment will support ABB’s Electrification, Motion and Automation businesses and expand manufacturing capacity for infrastructure sectors such as renewable energy, metro rail, data centres and industrial applications. Approximately 300..

Six WOLFF Cranes Handle 60,000 m³ Concrete for German Hospital

Six WOLFF tower cranes are playing a key role in constructing a new hospital complex in Memmingen, Germany, supporting large-scale material handling for the project. The facility is being built on a 7.7-hectare site and will feature six floors, around 480 beds and a gross floor area exceeding 75,000 sq m.Building shell works began recently in February 2025. One WOLFF 6531.12 Cross crane supported early site preparation before being dismantled in autumn 2025, while five remaining cranes continue operations. Over an average deployment period of 16 months, the cranes are expected to move approxim..

REC Funds Rs 115.6 Million CSR Support for Bihar Eye Hospital

REC recently committed Rs 115.6 million under its Corporate Social Responsibility (CSR) programme for the procurement of clinical and non-clinical equipment at Sankara Eye Hospital in Saharsa, Bihar. The initiative aims to strengthen healthcare infrastructure and improve access to specialised eye care services in the region.A Memorandum of Agreement (MoA) was recently signed between Pradeep Fellows, Executive Director (CSR), REC Limited, and Wg Cdr V. Shankar (Retd), Trustee and Executive Director of Sankara Eye Hospital, at the REC office in the SCOPE Complex, New Delhi.The support is expecte..